ArticleNeuro-oncology advances

Predicting prognosis outcomes of primary central nervous system lymphoma with high-dose methotrexate-based chemotherapeutic treatment using lipidomics.

Yi Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.